[Behavior of indanyl-carbenicillin (CP 15,464) following oral administration in man].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002228:Carbenicillin / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D011511:Proteus / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D002228:Carbenicillin
Le comportement de l'indanyl-carbénicilline (CP 15, 464) après administration orale chez l'homme.